Akili, Inc. (AKLI)
| Market Cap | 149.58M |
| Revenue (ttm) | 750,000 |
| Net Income (ttm) | -128.62M |
| Shares Out | 77.91M |
| EPS (ttm) | -141.21 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 221,251 |
| Open | 1.73 |
| Previous Close | 1.63 |
| Day's Range | 1.65 - 1.93 |
| 52-Week Range | 0.86 - 37.58 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 3.83 (+99.48%) |
| Earnings Date | Feb 13, 2023 |
About AKLI
Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts. [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 11 analysts, the average rating for AKLI stock is "Buy." The 12-month stock price forecast is $3.83, which is an increase of 99.48% from the latest price.
News
Akili to Participate in the Cowen 43rd Annual Health Care Conference
BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, will participate in the Cowen 43rd Annual Health Care Conference in Boston next month.
Akili to Champion Digital Therapeutics in Conjunction with J.P. Morgan Healthcare Conference
BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, will participate in the Biotech Showcase and Solebury 1x1 Management Access Conference, both happening alongs...
Pivotal Trial of EndeavorRxⓇ in Adolescents with ADHD Shows Robust Improvements in Attention and Broader Clinical Outcomes
BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today announced topline results of the STARS-ADHD-Adolescents label expansion study evaluating the efficacy a...
Akili Announces ADHD Expert Dr. Scott Kollins to Join as Chief Medical Officer
BOSTON--(BUSINESS WIRE)--Akili, Inc., a leading commercial digital medicine company, today announced the appointment of Scott Kollins, Ph.D., as chief medical officer, effective December 1, 2022. Dr...
Akili Reports Third Quarter 2022 Financial Results and Company Update
BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today reported its financial results for the quarter ended September 30, 2022, and provided an update on busi...
Financial Industry Veteran Mary Hentges Joins Akili's Board of Directors
BOSTON--(BUSINESS WIRE)--Akili, Inc. (NASDAQ: AKLI), a leading digital medicine company, today announced the appointment of Mary Hentges to the company's board of directors, effective October 25, 2022...
Akili to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Thursday, November 10 at 4:30 p.m. ET
BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, will host a conference call and webcast to review its third quarter financial results on Thursday, November 10,...
Akili Launches EndeavorRx® Expedition - A Direct-to-Patient Product Registry
BOSTON--(BUSINESS WIRE)---- $AKLI--Akili Interactive (“Akili”), a leading digital medicine company, today announced the EndeavorRx® Expedition product registry, which aims to obtain feedback from pati...
Akili to Participate in LifeSci Partners HealthTech Symposium
BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today announced that management will present at a fireside chat and participate in a panel discussion on prescr...
DNAA Stock Races 200% Higher as Akili SPAC Merger Closes
Shares in Social Capital Suvretta Holdings (NASDAQ: DNAA) rose sharply on news it completed its merger with Akili Interactive, which hopes to treat brain conditions using video games. After the marke...
Digital Medicine Leader Akili to List on Nasdaq Following Successful Business Combination with Social Capital Suvretta Holdings Corp. I
BOSTON & PALO ALTO, Calif.--(BUSINESS WIRE)---- $DNAA #DTx--Digital Medicine Leader Akili to List on Nasdaq Following Successful Business Combination with Social Capital Suvretta Holdings Corp. I
Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. III
WINSTON-SALEM, N,C. and PALO ALTO, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- ProKidney LP (“ProKidney”), a leading late clinical-stage cellular therapeutics company focused on CKD, and Social Capital...
PureTech Founded Entity Akili Announces Public Company Board of Director Nominees
BOSTON--(BUSINESS WIRE)--PureTech Founded Entity Akili Announces Public Company Board of Director Nominees
Akili Announces Public Company Board of Director Nominees
BOSTON--(BUSINESS WIRE)--Akili Interactive (“Akili”), a leading digital medicine company pioneering the development of cognitive treatments through game-changing technologies, today announced the nomi...
The American Journal of Psychiatry Publishes Data Demonstrating Akili Interactive's Digital Therapeutic AKL-T03 Improves Cognitive Impairments in Adults with Major Depressive Disorder When Combined with Antidepressant Medication
BOSTON--(BUSINESS WIRE)--Akili Interactive (“Akili”), a leading cognitive medicine company improving health through game-changing technologies, today announced that the American Journal of Psychiatry ...
Akili to Present at Chardan's Prescription Digital Therapeutics Half-Day Summit
BOSTON--(BUSINESS WIRE)--Akili Interactive (“Akili” or the “Company”), a leading digital medicine company pioneering the development of cognitive treatments through game-changing technologies, today a...
Game Industry Veteran Behind Bejeweled, Plants vs. Zombies Joins Akili as Chief Product Officer
BOSTON--(BUSINESS WIRE)--Akili Appoints Game Industry Veteran Jon David as Chief Product Officer
Akili Named to Fast Company's Annual List of the World's 50 Most Innovative Companies for 2022
BOSTON--(BUSINESS WIRE)---- $DNAA #DTx--Akili has been named to Fast Company's Annual list of the World's 50 Most Innovative Companies
Akili to Present at Cowen's 42nd Annual Health Care Conference
BOSTON--(BUSINESS WIRE)-- #DTx--Akili Management to Present at Cowen's 42nd Annual Health Care Conference
Akili to Speak on Integrating Digital Therapeutics Into Mainstream Healthcare at DTx West 2022
BOSTON--(BUSINESS WIRE)---- $DNAA #DTx--Akili Chief Financial Officer and Vice President of Marketing will speak at leading digital therapeutics conference, DTx West
PLOS ONE Publishes Clinical Study Results and EEG Data Showing Akili Digital Therapeutic EndeavorRx® Activates Systems in Brain Key to Attentional Functioning
BOSTON--(BUSINESS WIRE)---- $DNAA #DTx--New data published from a study of Akili's EndeavorRx shows the how the digital therapeutic effects brain activity of a child with ADHD
PureTech Founded Entity Akili Interactive Announces Filing of Registration Statement on S-4 in Connection with its Proposed Business Combination with Social Capital Suvretta Holdings Corp. I
BOSTON--(BUSINESS WIRE)--PureTech Founded Entity Akili Announces Filing of Registration Statement on S-4 in Connection with its Proposed Business Combination with SCS
Akili Interactive Announces Filing of Registration Statement on S-4 in Connection with its Proposed Business Combination with Social Capital Suvretta Holdings Corp. I
BOSTON & PALO ALTO, Calif.--(BUSINESS WIRE)---- $DNAA #DTx--Akili Announces Filing of S-4 in Connection with its Proposed Business Combination with Social Capital Suvretta Holdings Corp. I
DNAA Stock Alert: Chamath Palihapitiya's SPAC Preps for Akili Interactive Merger
DNAA stock is on the rise today after news its blank-check company, backed by Chamath Palihapitiya, is merging with Akili Interactive. The post DNAA Stock Alert: Chamath Palihapitiya's SPAC Preps for ...
Chamath Palihapitiya Announces SPAC Deal For Akili: Revolutionary Digital Therapy For Mental Illness
A biotech focused SPAC launched by frequent SPAC sponsor Chamath Palihapitiya announced a merger deal Wednesday morning. The SPAC Deal: Palihapitiya's Social Capital Suvretta Holdings Corp I (NASDAQ: ...